 randomized trial leuprolide acetate hysterectomy treatment leiomyomas Fifty premenopausal patients hysterectomy treatment symptomatic uterine leiomyomas size weeks gestation groups preoperative gonadotropin-releasing hormone agonist feasibility vaginal abdominal hysterectomy control group group preoperative gonadotropin-releasing hormone agonist patients Group months gonadotropin-releasing hormone agonist hysterectomy Patients groups similar respect age gravidity parity pretreatment uterine size hemoglobin hematocrit levels Patients group increase hemoglobin levels gm/dl decrease uterine volume ml weeks agonist therapy likely vaginal hysterectomy vs Patients group hospitalizations days administration gonadotropin-releasing hormone agonist months vaginal hysterectomy preferable abdominal hysterectomy patients uterine leiomyomas